Impact of organ dysfunction on outcomes in pediatric hypernatremia: a retrospective observational study

Akira Ishiguro(National Center For Child Health and Development), Shotaro Matsumoto(Society of Critical Care Medicine), Kentaro Ide(Society of Critical Care Medicine), Norihiko Tsuboi(National Center For Child Health and Development), Hiroki Kato(Society of Critical Care Medicine), Itaru Hayakawa(National Center For Child Health and Development), Kentaro Nishi(National Center For Child Health and Development), Kenji Ishikura(Kitasato University), Masao Ogura(Hokkaido University Hospital), Koichi Kamei(National Center For Child Health and Development)
Pediatric Nephrology
April 12, 2025
10.1007/s00467-025-06768-4
Cited by 1

Related Papers

Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial
|The Lancet|2014|450
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|278
Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease
|Clinical and Experimental Nephrology|2013|267
Epidemiology of pediatric chronic kidney disease/kidney failure: learning from registries and cohort studies
|Pediatric Nephrology|2021|149
A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment
|Kidney International|2014|135